Inventor · disambiguated record
David Charles Jackson
Also filed as: JACKSON DAVID · JACKSON DAVID C · JACKSON DAVID CHARLES
21 granted patents·13 pending applications·104 citations·filing 2000–2024
94Inventor score
Files withJACKSON DAVID CHARLES5UNIV MELBOURNE5Ena Therapeutics Pty Ltd4QUEENSLAND INST MED RES4Axelia Oncology Pty Ltd3
Top patents by PatentIndex Score
34 records- 0189US12017979B2MoleculesEna Respiratory Pty Ltd·Filed 2023·Granted Jun 25, 2024·2 cites·4 claims
- 0289US8986700B2Immunogenic lipopeptides comprising T-helper and cytotoxic T-lymphocyte (CTL) epitopesJACKSON DAVID·Filed 2010·Granted Mar 24, 2015·9 cites·18 claims
- 0387US11786458B2Immunostimulatory methodEna Respiratory Pty Ltd·Filed 2022·Granted Oct 17, 2023·1 cites·24 claims
- 0486US11351114B2Immunostimulatory methodEna Therapeutics Pty Ltd·Filed 2019·Granted Jun 7, 2022·3 cites·25 claims
- 0585US6685947B1T helper cell epitopesCSL LTD·Filed 2000·Granted Feb 3, 2004·21 cites·16 claims
- 0684US8367067B2Immunogenic lipopeptides comprising T-helper and B-cell epitopesQUEENSLAND INST MED RES·Filed 2009·Granted Feb 5, 2013·7 cites·13 claims
- 0784US7569225B2Immunogenic lipopeptides comprising T-helper and B-cell epitopesQUEENSLAND INST MED RES·Filed 2003·Granted Aug 4, 2009·21 cites·11 claims
- 0883US9089508B2Method of transfection and compositions thereforJACKSON DAVID CHARLES·Filed 2008·Granted Jul 28, 2015·11 cites·23 claims
- 0982US9889195B2Immunogenic composition and uses thereofUNIV MELBOURNE·Filed 2015·Granted Feb 13, 2018·3 cites·3 claims
- 1081US7241448B2T helper cell epitopesUNIV MELBOURNE·Filed 2006·Granted Jul 10, 2007·4 cites·16 claims
- 1179US10406100B2Immunostimulatory methodEna Therapeutics Pty Ltd·Filed 2017·Granted Sep 10, 2019·3 cites·13 claims
- 1276US12195557B2Optimised compoundsAxelia Oncology Pty Ltd·Filed 2018·Granted Jan 14, 2025·1 cites·5 claims
- 1375US9676819B2Immunostimulatory methodJACKSON DAVID CHARLES·Filed 2011·Granted Jun 13, 2017·3 cites·28 claims
- 1474US12124113B2Identification of contact lens wearers predisposed to contact lens discomfortCOOPERVISION INT LTD·Filed 2023·Granted Oct 22, 2024·0 cites·4 claims
- 1574US7572454B2T helper cell epitopesCSL LTD·Filed 2007·Granted Aug 11, 2009·1 cites·16 claims
- 1673US7097844B2T helper cell epitopesINST MEDICAL W & E HALL·Filed 2003·Granted Aug 29, 2006·5 cites·16 claims
- 1773US2025066416A1Optimised compoundsAxelia Oncology Pty Ltd·Filed 2024·Application pending·0 cites
- 1872US7833532B2Immunogenic lipopeptides comprising T-helper and cytotoxic T lymphocyte (CTL) epitopesQUEENSLAND INST MED RES·Filed 2003·Granted Nov 16, 2010·6 cites·32 claims
- 1964US8945551B2Biopolymer hybrid gel-depot delivery systemMAINWARING DAVID EDWARD·Filed 2010·Granted Feb 3, 2015·1 cites·24 claims
- 2064US7037507B2T helper cell epitopesCSL LTD·Filed 2004·Granted May 2, 2006·1 cites·16 claims
- 2163US11619832B2Identification of contact lens wearers predisposed to contact lens discomfortCOOPERVISION INT LTD·Filed 2019·Granted Apr 4, 2023·0 cites·15 claims
- 2262US9340622B2Synthetic immunogen useful for generating long lasting immunity and protection against pathogensAGREWALA JAVED N·Filed 2011·Granted May 17, 2016·1 cites·14 claims
- 2355US2022388950A1Novel moleculesAxelia Oncology Pty Ltd·Filed 2020·Application pending·0 cites
- 2451US2012064109A1Immunogenic composition and uses thereofJACKSON DAVID CHARLES·Filed 2011·Application pending·0 cites
- 2551US2011262473A1Synthetic vaccine componentUNIV MELBOURNE·Filed 2009·Application pending·0 cites
- 2650US2010266623A1Synthetic, self adjuvanting vaccinesUNIV MELBOURNE·Filed 2009·Application pending·0 cites
- 2747US2025345412A1Coronavirus VaccineThe Univesity of Melbourne Grattan Street·Filed 2021·Application pending·0 cites
- 2844US2002169264A1Polymers incorporating peptidesQUEENSLAND INST MED RES·Filed 2002·Application pending·0 cites
- 2940US2010129385A1Immunogenic moleculesJACKSON DAVID C·Filed 2006·Application pending·0 cites
- 3039US2009105155A1Truncated lhrh formulationsJACKSON DAVID CHARLES·Filed 2005·Application pending·0 cites
- 3138US2021177795A1Administering compoundsEna Therapeutics Pty Ltd·Filed 2018·Application pending·0 cites
- 3238US2017274068A1Immunological reagentUNIV MELBOURNE·Filed 2015·Application pending·0 cites
- 3337US2020147028A1Treatment of respiratory infection with a tlr2 agonistEna Therapeutics Pty Ltd·Filed 2018·Application pending·0 cites
- 3436US2010143405A1Immunotherapy of virus infectionJACKSON DAVID CHARLES·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Charles Jackson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →